Jeri Hilleman

Track

Insider profile

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 8% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Jeri Hilleman's trades of Novocure Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Novocure Ltd (NVCR)
Transaction date
Sale
Price
14.14
Quantity 79,802 -29.4%
Value US$2,915,423
US Novocure Ltd (NVCR)
Transaction date
Sale
Price
239.32
Quantity 29,299 -8.7%
Value US$4,609,699
US SI-BONE Inc (SIBN)
Transaction date
Proposed sale
Price
350.76
Quantity 29,996
Value US$549,164
US SI-BONE Inc (SIBN)
Transaction date
Planned sale
Price
28.00
Quantity 2,081 -11.9%
Value US$58,268
US SI-BONE Inc (SIBN)
Transaction date
Proposed sale
Price
28.74
Quantity 2,081
Value US$59,808
US SI-BONE Inc (SIBN)
Transaction date
Planned sale
Price
28.74
Quantity 2,081 -10.7%
Value US$59,808
US SI-BONE Inc (SIBN)
Transaction date
Planned sale
Price
13.81
Quantity 1,924 -23.3%
Value US$26,562
US Novocure Ltd (NVCR)
Transaction date
Planned sale
Price
69.61
Quantity 407 -13.8%
Value US$28,331
US SI-BONE Inc (SIBN)
Transaction date
Planned sale
Price
33.71
Quantity 4,400 -34.8%
Value US$148,324
US Novocure Ltd (NVCR)
Transaction date
Planned sale
Price
166.40
Quantity 2,500 -42.4%
Value US$416,000
Transaction date
Purchase
Price
5.25
Quantity 1,000 +inf%
Value US$5,250
Transaction date
Planned sale
Price
32.34
Quantity 4,709 -12.9%
Value US$152,299
Transaction date
Planned sale
Price
32.34
Quantity 16,491 -31.1%
Value US$533,354
Transaction date
Planned sale
Price
32.07
Quantity 30,000 -48.5%
Value US$962,091
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-03 2026-06-02
US Novocure Ltd (NVCR)
S Sale
79,802 -29.4%
14.14
US$2,915,423 		79,802 -29.4% 14.14 US$2,915,423
2025-06-04 2025-06-03
US Novocure Ltd (NVCR)
S Sale
29,299 -8.7%
239.32
US$4,609,699 		29,299 -8.7% 239.32 US$4,609,699
2023-06-20 2023-06-20
US SI-BONE Inc (SIBN)
PrS Proposed sale
29,996
350.76
US$549,164 		29,996 350.76 US$549,164
2023-06-20 2023-06-20
US SI-BONE Inc (SIBN)
PlS Planned sale
2,081 -11.9%
28.00
US$58,268 		2,081 -11.9% 28.00 US$58,268
2023-06-16 2023-06-16
US SI-BONE Inc (SIBN)
PrS Proposed sale
2,081
28.74
US$59,808 		2,081 28.74 US$59,808
2023-06-20 2023-06-15
US SI-BONE Inc (SIBN)
PlS Planned sale
2,081 -10.7%
28.74
US$59,808 		2,081 -10.7% 28.74 US$59,808
2022-06-14 2022-06-13
US SI-BONE Inc (SIBN)
PlS Planned sale
1,924 -23.3%
13.81
US$26,562 		1,924 -23.3% 13.81 US$26,562
2022-06-16 2022-06-10
US Novocure Ltd (NVCR)
PlS Planned sale
407 -13.8%
69.61
US$28,331 		407 -13.8% 69.61 US$28,331
2021-06-28 2021-06-25
US SI-BONE Inc (SIBN)
PlS Planned sale
4,400 -34.8%
33.71
US$148,324 		4,400 -34.8% 33.71 US$148,324
2020-12-22 2020-12-18
US Novocure Ltd (NVCR)
PlS Planned sale
2,500 -42.4%
166.40
US$416,000 		2,500 -42.4% 166.40 US$416,000
2019-06-27 2019-06-26
B Purchase
1,000 +inf%
5.25
US$5,250 		1,000 +inf% 5.25 US$5,250
2019-04-03 2019-04-02
PlS Planned sale
4,709 -12.9%
32.34
US$152,299 		4,709 -12.9% 32.34 US$152,299
2019-04-03 2019-04-02
PlS Planned sale
16,491 -31.1%
32.34
US$533,354 		16,491 -31.1% 32.34 US$533,354
2019-04-03 2019-04-01
PlS Planned sale
30,000 -48.5%
32.07
US$962,091 		30,000 -48.5% 32.07 US$962,091
2004-05-14 2004-05-13
PlS Planned sale
10,000 -15.8%
24.70
US$247,000 		10,000 -15.8% 24.70 US$247,000